New Clinical Trials for MPNs in 2021 and Beyond Myeloproliferative neoplasm (MPN) experts answer common questions on clinical trials during the time of COVID-19. Ruth Fein, Gabriela Hobbs, MD, Angela Fleischman, MD, PhD
Research Findings and Resources for MPN-Related Depression Nearly one-quarter of myeloproliferative neoplasm (MPN) patients experience depressive symptoms; you are not alone. See research findings and resources.
How Do Racial and Socioeconomic Disparities Affect MPN Care? Ruth Fein, Taja Shabazz-Simmons, Irum Khan, MD, Karen Bullock, PhD, LCSW
Can Telemedicine Improve the Quality of Your MPN Care? Esther Schorr, Suman Kambhampati, MD, Aaron Gerds, MD
Creating a Sustainable Support Network for MPN Patients Esther Schorr, Cheryl Petruk, MBA, BMgt, CHRP, Susan Hedlund, MSW, LCSW
MPN Treatment: Managing Itching, Sweating and Bone Pain Naveen Pemmaraju, MD, Rodney Haltom, Julie Huynh-Lu, PA-C, Andrew Schorr
MPN Side Effects: Weight Gain and Cognitive Issues Naveen Pemmaraju, MD, Julie Huynh-Lu, PA-C, Rodney Haltom, Andrew Schorr
Is There Help for Fatigue and Insomnia from MPN Treatment? Naveen Pemmaraju, MD, Rodney Haltom, Julie Huynh-Lu, PA-C, Andrew Schorr